Calm/Storm

We believe that these solutions cover a wide spectrum that includes the optimization of physical, mental, social and financial wellness, serving as the core components that will undergird the conscious, communal shift toward a healthier future. Our primary goal is to empower passionate founders who develop innovative ideas that impact all bodies. We're investing in more than just potential, we’re doubling down on the endless realm of human potential. With efficiency in mind, we like to spend our first meeting getting to understand the founder(s) first. Your first conversation may be with one of our Partners or investors. Each member of our team has a voice and it's respected at the table. After that conversation, we huddle to connect the dots, reflect on your story and think. From there we spend time with information shared and will come back with deeper questions that move the relationship forward. These are not questions to occupy your inbox, but questions formulated on our path to deep conviction. HEALTH Healthcare has reached an inflection point. The landscape is rapidly shifting towards value based care, deep personalization, and an endless appetite for connected data that will forever change the way we communicate with health providers, our families and ourselves. WELLNESS The wellness industry is a $4.5T opportunity, as more consumers seek to reduce their healthcare costs while exploring ways to be healthier and happier across physical, mental, social and spiritual dimensions of their lives. We seek innovative companies using technology to deliver benefits that are meaningful, measurable and scalable. TECHNOLOGY Software will continue to impact the world in ways never imagined. We're firm in our belief of embracing technology as the conduit for optimization. Innovative applications and connected hardware will continue to change behaviors, augment processes and provide stable infrastructure to advance the world's capabilities. STAGE & CHECK SIZE Our funding decisions are made by consensus. There will always be an internal deal champion that will serve as your lead investor. We practice a rigorous diligence process that can sometimes be complex or very swift - but we typically are able to gather the information we need in 2 weeks or less, once we've aligned on our potential partnership. It's our obligation to earn your trust and build on our relationship. To that end we run a transparent process, with no "GOTCHA" moments. We will work closely with the founder(s) to determine our entry point that makes sense. We are hands-on investors, we set out with a 90 day action plan to be additive at the outset. Stage: Seed-Series A Size: $500K-$3MM Fund Size: $50M As the capital landscape continues to evolve, we remain flexible to understand the specific needs of the entrepreneur. We have a framework that directs our investing. In order for us to spend dedicated time with our founders, we target 6-8 investments per year. These companies typically have a working prototype product getting user feedback or generating revenue, approaching product market fit. On occasion, we invest in exceptional teams at the concept level.

Muse Capital is an early stage venture fund investing in consumer tech, with a focus on large underserved markets poised for disruption. They focus on investing in products, services and solutions to meet the needs of tomorrow’s increasingly diverse society across how we care (women’s health, digital health, and childcare), how we live (wellness and sustainability), and how we play (gaming, entertainment, web3, and sports tech). Muse Capital’s expertise is sourcing and executing on business development opportunities for their entrepreneurs, leveraging the partners 20+ years of accelerating and operating businesses in both private and public sectors, with their global network of decision makers across F500's, entertainment, sports teams/owners, global investors, and world class tech entrepreneurs. Given their highly strategic value add, they are able to access oversubscribed deals and invest before or alongside some of the top funds in the valley including Andreessen Horowitz, Google Ventures, Forerunner, and Lightspeed to name just a few. Muse Capital’s current fund is a $45m platform dedicated to doubling down on their established track record across the consumer space, and a knack for spotting super-trends and talent early on. Their portfolio of 40+ investments includes Clarity Money (sold to Goldman Sachs), Mahmee (telehealth for new mothers, series A lead by Goldman Sachs), Midi (disrupting the $50B menopause space), Kinside (digitizing the $150B childcare industry), and Beekeeper’s Naturals (replacing the modern medicine cabinet with natural products). The team has also gained exclusive access for their strategic LPs to direct investments into prestigious later stage deals including Robinhood and Byju’s. As a female lead team of conscious capitalists, Muse Capital is a staunch advocate for diversity as better business, and proud to have a portfolio which is 50% minority/female.

Through philanthropic funding, collaborations, and intergenerational partnerships, Hopelab works at the intersection of tech and mental health alongside entrepreneurs, funders, researchers, and young change-makers to create systems change and build a thriving future for underserved young people. UNITED BY A BOLD IDEA With backing from The Omidyar Group, Hopelab’s team is united by a common desire, from our founders, to catalyze social impact and empower young people. Hopelab was created as a lab to explore the idea that stable philanthropic funding might support a deeper exploration of the way translational research, technology, and investment opportunities can bolster resilience and improve the health and well-being of young people. To this day, that remains a guiding vision of Hopelab. Re-Mission, Hopelab’s first project, was inspired by co-founder Pam Omidyar’s bold idea to create a video game to help young cancer patients comply with treatment. That legacy continues to guide the organization’s mission-driven work to help build a more inclusive and equitable future for young people, especially BIPOC and LGBTQ+ youth. EVERY DAY, THE TEAM AT HOPELAB ASPIRES TO BE... Equity Advocates: We center equity in all facets of our work and recognize that systems of oppression, like racism, homophobia, transphobia, and wealth inequities, are connected – dismantling them benefits everyone. We passionately work to create more equitable health outcomes for young people from underinvested groups. Intergenerational Collaborators: We believe that more equitable outcomes for young people require intergenerational partnership and a shift in who holds power. We support co-creation between young people and adults, and shifting of power toward young people. We believe that nothing should be built for young people without the equitable engagement of young people. Compassionate Optimists: We are unwavering in our pursuit of a more compassionate, better world now and for generations to come. Joy and hope can feel radical in today’s world; we embrace them to fuel possibility and innovation in service to a more equitable future with concrete outcomes for young people. Relationship Builders: Complex systems are made up of interconnected relationships, and we believe that systems change must start with authentic connection. We are connectors, and our work bridges across sectors, disciplines, and perspectives. Our work gains strength from a diverse set of voices and approaches. Expansive Learners: We develop multi-disciplinary teams to solve complex issues by drawing upon, learning from, and integrating many fields and methods, including rigorous science, psychology, public health, impact investing, design, and the lived experiences of young people and the adults in their lives.

Noetic invests globally to build emerging technologies in molecular therapeutics/biotech, digital health, medical devices, and wellness with a focus on mental health, pain, and other complications resulting from the central nervous system. About no•et•ic “From the Greek noēsis/ noētikos meaning inner wisdom, direct knowing, or subjective understanding” Noetic science refers to a multidisciplinary field that brings objective scientific tools and techniques together with subjective understanding to study the full range of human experience. Mission: Our mission is to nurture the scientific advancement of mental, emotional, and physiological health by investing in emerging therapies, modalities, and sciences that are committed to optimizing our human experience. Commitment: We are committed to developing sustainable therapies, products, and services that are innovative, safe, and accessible to create a better mental health landscape for current and future generations. Focus: CNS-targetted therapeutics and related sustainable solutions for mental health and physical well being.

We aim to support passionate entrepreneurs building visionary brands in positive living that will make the daily lives of consumers healthier, happier and more meaningful. We seek to partner with companies that are narrowing The Wellness Gap: the quantifiable delta that has grown dramatically over the past two decades as economic indicators such as GDP per capita have increased while measures of overall wellbeing, including physical and mental health, have stagnated or decreased. We are most focused on overlooked or stigmatized communities that have resulted in underserved markets. These are the areas where we see opportunity: Disruptive Healthcare Care Economy Consumer Wellbeing Connection & Community With a particular interest in the following demographics: Women Immigrants Caregivers Aging Adults Gen Z

We build and invest in companies that positively impact human health with smart solutions, breakthrough science and technology. Our focus is on innovation in digital healthcare, connected medical devices, and life sciences We focus on therapeutic and preventive technology solutions addressing unmet needs in some of the most vulnerable segments of society: women, children and the elderly. Digital transformation will continue to shape our lives and has the potential to transform care. We aim to build and support Digital Health & Life Sciences companies working to make healthcare smarter, using data to improve care and outcomes, and reinventing the patient journey. Our vision for the future of healthcare guides our investment strategy. A data driven digital transformation will shape the future of healthcare. The traditional biopharma model will evolve into an integrated model, where prevention, precision cure, and care management will coexist in a highly personalized patient-centric solution. Our goal is to support the creation of life transforming care products and therapies. We believe the future of healthcare lies in supporting the next-generation of founders and teams who will lead us there. What do we look for?Innovation and groundbreaking opportunities in our sectors of focus: digital health, life sciences, tech-enabled care delivery, and connected devices Innovative treatments for Central Nervous System (CNS) disorders, in particular neurodevelopmental disorders, mental health and epilepsy Founders and teams with domain expertise who seek collaborative investment partners Investments that span development and commercial phases, with a focus on early stage opportunities (Pre-Seed to Series A). Our investment approachOur investment approach combines direct investments in early-stage companies with venture creation from bold ideas in global innovation hubs Our goal is to enable talented entrepreneurs to scale more quickly and effectively through access to our capital, enterprise capabilities and consumer touchpoints, while offering expertise and insights from Angelini’s unique perspective. We invest primarily across Europe, North America and Israel, recognizing that healthcare technology innovation is occurring in many cities around the world. We have committed €300M for investments and company creation in digital health and life sciences. What do we commit to you?Active and involved healthcare investors who operate with integrity, approachability, and transparency A team of passionate healthcare and venture capital experts diverse in demographic and experience A track record of success and experience navigating the ups and downs of early-stage company building Access to a world-class advisory board to leverage C-level experience, expertise, and leadership in healthcare